Lipid-Lowering Drugs: Statins and Miscellaneous Agents
Atherosclerosis III: Management
Lipid Absorption
Drugs for Treatment of Constipation-Predominant IBS
Blood Studies for Cardiovascular System III: Serum Lipid Profile
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
您也可能阅读
通过共同作者、期刊和引用图与本文相关的文章。
Updated: Sep 19, 2025

Assessing Whole-Body Lipid-Handling Capacity in Mice
Published on: November 24, 2020
Mingliang Zhang1, Weimin Jiang2, Jie Yin1
1College of Animal Science and Technology, Hunan Agriculture University, Changsha 410128, China; Yuelushan Laboratory, Changsha 410128, China.
益生菌干预措施通过影响肠道微生物群和宿主脂质代谢,在管理高甘油三糖血症方面表现有前途. 对下一代益生菌的进一步研究可能为这种常见的脂质异常提供新的治疗策略.
科学领域:
背景情况:
研究的目的:
主要方法:
主要成果:
结论: